ERAP2 and non-small cell lung carcinoma: The GCTCCA haplotype, coding for active ERAP2, allows this enzyme, either alone or in a heterodimer with ERAP1 to destroy stimulating epitopes in never-smokers and protective epitopes in smokers, resulting in a lack of ERAP effect on NSCLC risk.